Plaintiffs are opposing the motion made by AstraZeneca Pharmaceuticals L.P. and McKesson Corp. to dismiss 58 cases.
The plaintiffs, represented by Los Angeles’ Girardi & Keese, said in a filing with U.S. District Judge Dale Fischer of the Central District of California that they have produced records to defendants proving that the claims are viable. They also said that they have been actively participating in discovery by producing fact sheets and medical records.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
